Compositions and methods for treating a posterior segment of an eye

Details for Australian Patent Application No. 2004289300 (hide)

Owner Allergan, Inc.

Inventors Chang, James N.; Whitcup, Scott M.; Lyons, Robert T.; Trogden, John T.

Agent Davies Collison Cave

Pub. Number AU-B-2004289300

PCT Pub. Number WO2005/046641

Priority 60/530,062 16.12.03 US; 10/966,764 14.10.04 US; 60/519,237 12.11.03 US

Filing date 8 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 16 July 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/573 (2006.01)

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/046641 Priority application(s): WO2005/046641

16 July 2009 Application Accepted

  Published as AU-B-2004289300

12 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289303-Fused heterocyclic compounds

2004289297-Compositions, kits, and methods for the treatment of conditions associated with elevated cholesterol levels